Tag:
AMS
Latest Headlines
Latest Headlines
Endo CEO: More buyouts, but smaller
You could look at Endo Pharmaceuticals as a mini-illustration of pharma's current challenges--and the strategies for meeting them. The company's lead product, Lidoderm, loses patent protection in
